Clinical Study

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration

Table 1

Treatments during 12 months.

Mean PDT sessions 1 . 1 ± 0 . 3 (1-2)
Mean IVR 2 . 9 ± 1 . 3 (2–6)
Total number of combined treatments
 1 PDT + 2 IVR22 (57.9%)
 1 PDT + 3–5 IVR11 (28.9%)
 2 PDT + 4–6 IVR5 (13.2%)

IVR: intravitreal injection of ranibizumab, PDT: photodynamic therapy.